MHH project wins start-up funding competition organised by Lower Saxony research incubator Institute for Biomedical Translation Lower Saxony.
The Times of Israel on MSN
In world first, Israeli scientists use RNA-based gene therapy to stop ALS deterioration
By adding a microRNA molecule to ALS models, Tel Aviv University, Ben-Gurion University and Weizmann Institute researchers ...
Merck rebounds on pipeline wins and a $9.2B Cidara deal, but mixed trends and Keytruda risks keep investors weighing next moves.
Emerging research highlights the transformative potential of m6A RNA modification in the diagnosis and treatment of ...
This report describes and explains the RNA targeting small molecules therapeutics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report ...
Key opportunities in the RNA targeting small molecules therapeutics market include growth in RNA splicing modifications, neurodegenerative diseases, drug discovery, and pharma-biotech sectors.
WVE-007, an INHBE GalNAc-siRNA for obesity designed to drive fat loss while preserving muscle mass, achieved dose-dependent, mean reductions of ...
In this GEN webinar we will discuss emerging purification and quantitation techniques that work for the new generation of mRNA therapeutics beyond COVID-19 vaccines.
CHAPEROME explores how chaperones actively control protein synthesis on the ribosome. • Keeping cells healthy: The project investigates how chaperones and translation factors cooperate to help cells ...
In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback